dr hab. Agnieszka Nikiforuk
Strona główna
/
Instytut
/
Pracownicy
/
dr hab. Agnieszka Nikiforuk
dr hab. Agnieszka Nikiforuk
Dokonania naukowe
- Publikacje
Quetiapine ameliorates stress-induced cognitive inflexibility in rats.
Autorzy: Nikiforuk A
DOI: 10.1016/j.neuropharm.2012.06.042
Date: 2012-06-01
Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats.
Autorzy: Nikiforuk A, Popik P
DOI: 10.1007/s00213-011-2487-x
Date: 2011-09-01
Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats.
Autorzy: Nikiforuk A
DOI: 10.1016/j.bbr.2011.09.006
Date: 2011-09-01
Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner.
Autorzy: Nikiforuk A, Kos T, Rafa D, Behl B, Bespalov A, Popik P
DOI: 10.1016/j.neuropharm.2011.04.010
Date: 2011-04-01
The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration.
Autorzy: Nikiforuk A, Kos T, Wesołowska A
DOI: 10.1007/s00213-011-2297-1
Date: 2011-04-01
The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice.
Autorzy: Kos T, Nikiforuk A, Rafa D, Popik P
DOI: 10.1007/s00213-010-2102-6
Date: 2010-12-01
Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats.
Autorzy: Nikiforuk A, Popik P, Drescher KU, van Gaalen M, Relo AL, Mezler M, Marek G, Schoemaker H, Gross G, Bespalov A
DOI: 10.1124/jpet.110.170506
Date: 2010-08-01
Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants.
Autorzy: Nikiforuk A, Popik P
DOI: 10.1016/j.psyneuen.2010.06.001
Date: 2010-06-01
Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats.
Autorzy: Nikiforuk A, Gołembiowska K, Popik P
DOI: 10.1016/j.euroneuro.2009.08.001
Date: 2010-01-01
Synthesis and preliminary pharmacological evaluation of imidazo[2,1-f]purine-2,4-dione derivatives.
Autorzy: Zagórska A, Jurczyk S, Pawłowski M, Dybała M, Nowak G, Tatarczyńska E, Nikiforuk A, Chojnacka-Wójcik E
DOI: 10.1016/j.ejmech.2009.07.014
Date: 2009-07-01